Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service？ Thank you for choosing ACROBiosystems. Would you rate our product and service？
Here come GMP Grade Cytokines！Free Sample is available！ Here come GMP Grade Cytokines！Free Sample is available！
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Fingolimod Hydrochloride | FTY-720A; TDI-132; FTY-720 | Approved | Novartis Pharma Ag | Gilenia, Imusera, 捷灵亚, Gilenya | United States | Multiple Sclerosis | Novartis Pharma Ag | 2010-09-21 | Cerebral Hemorrhage, Traumatic; Amyotrophic Lateral Sclerosis; Uveitis; Asthma; Intracranial Hemorrhage, Hypertensive; Brain Edema; Hypesthesia; Breast Neoplasms; Optic Neuritis; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Cerebral Hemorrhage; Renal Insufficiency; Schizophrenia; Rett Syndrome; Pain; Intracranial Hemorrhages; Rejection of renal transplantation; Peripheral Nervous System Diseases; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Details |
| Ozanimod hydrochloride | CYM-5442; RPC-1063 | Approved | The Scripps Research Institute Inc | 热珀西亚, Zeposia | United States | Multiple Sclerosis | Bristol-Myers Squibb Company | 2020-03-25 | Multiple Sclerosis, Relapsing-Remitting; Digestive System Diseases; Gram-Negative Bacterial Infections; Coronavirus Disease 2019 (COVID-19); Multiple Sclerosis; Liver Diseases; Colitis, Ulcerative; Crohn Disease | Details |
| Etrasimod arginine | APD-334; MXE5EMA09L; APD-334 L-Arginine; PF-07915503 | Approved | Arena Pharmaceuticals Inc | VELSIPITY | United States | Colitis, Ulcerative | Pfizer Inc | 2023-10-12 | Inflammatory Bowel Diseases; Pyoderma Gangrenosum; Alopecia Areata; Intraabdominal Infections; Cholangitis, Sclerosing; Eosinophilic Esophagitis; Colitis, Ulcerative; Dermatitis, Atopic; Eczema; Crohn Disease | Details |
| Fingolimod lauryl sulfate | Approved | Handa Neuroscience LLC | Tascenso ODT | United States | Multiple Sclerosis | Handa Neuroscience LLC | 2021-10-18 | Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis | Details | |
| Siponimod | NVP-BAF312-AEA; BAF-312; NVP-BAF312-NX | Approved | Novartis Pharma Ag | Mayzent | United States | Multiple Sclerosis | Novartis Pharma Ag | 2019-03-26 | Multiple Sclerosis, Relapsing-Remitting; Polymyositis; Cerebral Hemorrhage; Dermatomyositis; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Stroke; Hepatic Insufficiency | Details |
| Fingolimod Hydrochloride | FTY-720A; TDI-132; FTY-720 | Approved | Novartis Pharma Ag | Gilenia, Imusera, 捷灵亚, Gilenya | United States | Multiple Sclerosis | Novartis Pharma Ag | 2010-09-21 | Cerebral Hemorrhage, Traumatic; Amyotrophic Lateral Sclerosis; Uveitis; Asthma; Intracranial Hemorrhage, Hypertensive; Brain Edema; Hypesthesia; Breast Neoplasms; Optic Neuritis; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Cerebral Hemorrhage; Renal Insufficiency; Schizophrenia; Rett Syndrome; Pain; Intracranial Hemorrhages; Rejection of renal transplantation; Peripheral Nervous System Diseases; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Details |
| Ozanimod hydrochloride | CYM-5442; RPC-1063 | Approved | The Scripps Research Institute Inc | 热珀西亚, Zeposia | United States | Multiple Sclerosis | Bristol-Myers Squibb Company | 2020-03-25 | Multiple Sclerosis, Relapsing-Remitting; Digestive System Diseases; Gram-Negative Bacterial Infections; Coronavirus Disease 2019 (COVID-19); Multiple Sclerosis; Liver Diseases; Colitis, Ulcerative; Crohn Disease | Details |
| Etrasimod arginine | APD-334; MXE5EMA09L; APD-334 L-Arginine; PF-07915503 | Approved | Arena Pharmaceuticals Inc | VELSIPITY | United States | Colitis, Ulcerative | Pfizer Inc | 2023-10-12 | Inflammatory Bowel Diseases; Pyoderma Gangrenosum; Alopecia Areata; Intraabdominal Infections; Cholangitis, Sclerosing; Eosinophilic Esophagitis; Colitis, Ulcerative; Dermatitis, Atopic; Eczema; Crohn Disease | Details |
| Fingolimod lauryl sulfate | Approved | Handa Neuroscience LLC | Tascenso ODT | United States | Multiple Sclerosis | Handa Neuroscience LLC | 2021-10-18 | Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis | Details | |
| Siponimod | NVP-BAF312-AEA; BAF-312; NVP-BAF312-NX | Approved | Novartis Pharma Ag | Mayzent | United States | Multiple Sclerosis | Novartis Pharma Ag | 2019-03-26 | Multiple Sclerosis, Relapsing-Remitting; Polymyositis; Cerebral Hemorrhage; Dermatomyositis; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Stroke; Hepatic Insufficiency | Details |
This web search service is supported by Google Inc.
アクロバイオシステムズの公式アカウント
A-Z
